Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2025-12-26 @ 12:34 AM
Study NCT ID:
NCT00161993
Status:
COMPLETED
Last Update Posted:
2021-08-24
First Post:
2005-09-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia)
Sponsor:
Baxalta now part of Shire
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-06-13
Start Date Type:
ACTUAL
Primary Completion Date:
2003-09-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2003-09-24
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-08
First Submit QC Date:
None
Study First Post Date:
2005-09-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-22
Last Update Post Date:
2021-08-24
Last Update Post Date Type:
ACTUAL